MRI screening for brain metastases in aggressive breast cancer
Part of Brain & nervous system, Cancer, Skin clinical trials.
This trial uses an MRI scan to look for early signs of breast cancer spreading to the brain in people with certain aggressive breast cancer types (triple-negative or HER2-positive) that are stage IIb or III. The goal is to find and treat brain metastases earlier, before they cause symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have triple-negative or HER2-positive breast cancer, stage IIb or III.
- You have no symptoms that suggest cancer might have spread to the brain.
- You are not pregnant and have good kidney function.
- You are willing to sign a consent form to take part.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether regular brain MRI scans can help detect brain metastases early in patients with stage IV breast cancer who do not yet have any known brain metastases. The goal is to see if early detection improves outcomes.
This study tests whether regular brain scans (surveillance) help spot brain metastases early in people with HER2-positive breast cancer that has spread to other parts of the body. Participation involves being randomly assigned to either routine brain scans or no extra scans to see which approach is better.
This study uses breast MRI scans to see whether neoadjuvant (before-surgery) chemotherapy is working. If you qualify, you’ll have MRI scans to help doctors understand how your breast cancer responds to standard treatment.
This trial studies brain scan findings to see if specific imaging markers can help understand or predict outcomes in people with brain metastases. It may help researchers improve how brain metastases are evaluated before radiation treatment.
This study is looking at whether routine brain scans (MRI) at the time of diagnosis of metastatic breast cancer can help detect brain metastases early, even before they cause symptoms. It aims to understand how common brain metastases are in high-risk breast cancer and whether early detection can help guide treatment decisions. This may be relevant for people with certain types of breast cancer that have spread to other organs.
This trial checks whether taking screening brain MRI scans in people with stage IV breast cancer helps find brain involvement earlier. It may help guide treatment decisions for those who would otherwise only get brain imaging after symptoms start.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.